Record overview
Status and phase
Status: RECRUITING
Phase: PHASE1, PHASE2
Sponsor: AstraZeneca
Condition: Metastatic Prostate Cancer
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.